Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential (Q46625935)
Jump to navigation
Jump to search
scientific article published on 12 December 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential |
scientific article published on 12 December 2015 |
Statements
1 reference
Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential (English)
1 reference
Peter G Ruminski
1 reference
Mark Massa
1 reference
Joseph Strohbach
1 reference
Cathleen E Hanau
1 reference
Michelle Schmidt
1 reference
Jeffrey A Scholten
1 reference
Theresa R Fletcher
1 reference
Bruce C Hamper
1 reference
Jeffery N Carroll
1 reference
Huey S Shieh
1 reference
Nicole Caspers
1 reference
Brandon Collins
1 reference
Margaret Grapperhaus
1 reference
Katherine E Palmquist
1 reference
Joe Collins
1 reference
John E Baldus
1 reference
Jeffrey Hitchcock
1 reference
H Peter Kleine
1 reference
Michael D Rogers
1 reference
Joseph McDonald
1 reference
Grace E Munie
1 reference
Dean M Messing
1 reference
Silvia Portolan
1 reference
Laurence O Whiteley
1 reference
Teresa Sunyer
1 reference
Mark E Schnute
1 reference
12 December 2015
1 reference
59
1 reference
1
1 reference
313-327
1 reference